Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BNTX BioNTech SE American Depositary Share | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $96.06 -2.6% | $15.06 -2.0% |
| StockIQ Score | 31F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 21F | 13F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 50C- | 50C- |
| Quality | — | 50C- |
| Risk | 42D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BioNTech (BNTX) outperforms Ascentage Pharma (AAPG) in investor and technical strength, with scores of 59 and 61 versus 37 and 18, respectively. BNTX also carries a stronger "MODERATE" rating compared to AAPG’s "WEAK." However, AAPG’s growth score of 50 is the only available metric where it leads, though no fundamental or valuation data is provided for BNTX.